CONTINUE TO SITE
OR WAIT null SECS
- About Us
- Advertise
- Editorial
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Overcoming Supply Chain Challenges
Chip Davis recaps the organization’s Distribution Management Conference and addresses distributors’ preparedness for DSCSA implementation.
In this exclusive PC Podcast interview, Chip Davis, president and CEO of the Healthcare Distribution Alliance (HDA), a national organization that represents primary pharmaceutical distributors, discusses:
- The benefits of the Distribution Management Conference, and the value it provides for the industry
- A three-year check-in since his last chat with Pharmaceutical Commerce, including a look at how the challenges presented to distributors now differ, and how they are being addressed
- Progress that has been made toward full connectivity since the FDA announced a “stabilization period” to finalize implementation of the DSCSA before November 2024, along with some of the most significant issues for trading partners
- Some of the root causes of drug shortages, and how distributors are work to mitigate them
- Key initiatives and plans that the HDA is focused on for the second half of 2024, and how these will shape the future of the pharmaceutical supply chain.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on Audioboom, Spotify, or iHeart.
Related Content:
